Sanctus Musafiri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sanctus Musafiri has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Guy Gaston Brusselle
Ghent University Hospital, Ghent, Belgium
2 shared publications - Jan P. van Meerbeeck
Antwerp University Hospital, Edegem, Belgium
2 shared publications - Pierre Claver Rutayisire
Applied Statistics Department, University of Rwanda, University Avenue 1, B.P 117, Butare, Rwanda
2 shared publications Benoit Seminega
National University of Rwanda, Faculty of Medicine, University Avenue, PO box 117, Butare, Rwanda
1 shared publication- Eric Derom
Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
1 shared publication G Joos
1 shared publication
Latest Publications
- Open Access
- 11 May 2012
- Published by S. Karger AG in Respiration
- Vol. 85 (4) , 297-304
Spirometric Reference Values for an East-African Population
Background: Accurate interpretation of lung function testing requires appropriate reference values. Unfortunately, few African countries have produced spirometric reference values for their populations. Objectives: The present study was carried out in order to establish normal lung function values for subjects living in Rwanda, East Africa. Methods: The study was conducted in Kigali, capital of Rwanda, and in the rural district of Huye in southern Rwanda. The variables studied were forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and peak expiratory flow. Multiple regression analysis was performed using age, height, weight and BMI as independent variables to obtain predicted equations for both sexes. Results: Predicted equations for normal lung functions were obtained from 740 healthy nonsmoking subjects; 394 were females and 346 were males. Minor differences in FEV1 and FVC were observed in comparison with other studies of Africans, African-Americans (difference in FEV1 and FVC of less than 5%), Chinese and Indians. When compared with selected studies from Caucasians and white Americans, our results for FEV1 and FVC were 9-12% and 16-18% lower in men and 12-23% and 17-28% lower in women, respectively. Conclusions: This study provides reference values for pulmonary function in a healthy, nonsmoking Rwandan population and enables comparisons to be made with other prediction equations from other populations. Spirometric reference values in our study were similar to those obtained in a study of black Americans by Hankinson et al. [Am J Crit Care Med 1999;159:179-187].
- 11 May 2012
- Published by S. Karger AG in Respiration
- Vol. 85 (4) , 297-304
Open AccessSpirometric Reference Values for an East-African Population
Background: Accurate interpretation of lung function testing requires appropriate reference values. Unfortunately, few African countries have produced spirometric reference values for their populations. Objectives: The present study was carried out in order to establish normal lung function values for subjects living in Rwanda, East Africa. Methods: The study was conducted in Kigali, capital of Rwanda, and in the rural district of Huye in southern Rwanda. The variables studied were forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and peak expiratory flow. Multiple regression analysis was performed using age, height, weight and BMI as independent variables to obtain predicted equations for both sexes. Results: Predicted equations for normal lung functions were obtained from 740 healthy nonsmoking subjects; 394 were females and 346 were males. Minor differences in FEV1 and FVC were observed in comparison with other studies of Africans, African-Americans (difference in FEV1 and FVC of less than 5%), Chinese and Indians. When compared with selected studies from Caucasians and white Americans, our results for FEV1 and FVC were 9-12% and 16-18% lower in men and 12-23% and 17-28% lower in women, respectively. Conclusions: This study provides reference values for pulmonary function in a healthy, nonsmoking Rwandan population and enables comparisons to be made with other prediction equations from other populations. Spirometric reference values in our study were similar to those obtained in a study of black Americans by Hankinson et al. [Am J Crit Care Med 1999;159:179-187].
- 25 July 2011
- Published by Elsevier in Respiratory Medicine
- Vol. 105 (11) , 1596-1605
Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country
- 25 July 2011
- Published by Elsevier in Respiratory Medicine
- Vol. 105 (11) , 1596-1605
Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country
- 1 January 2011
- Published by Muhimbili University of Health and Allied Sciences in East African Journal of Public Health
- Vol. 8 (2) , 173-176
Asthma, atopy and COPD in sub-Saharan countries: the challenges.
Asthma and COPD are the most important chronic airways diseases worldwide. Urbanization and westernization of African countries are important factors for the development of chronic respiratory diseases. Unfortunately for many reasons, only few studies on atopy, asthma and COPD have been carried out in Africa and risk factors are not well known on the continent. Moreover, in many African countries drugs for asthma and COPD are either lacking or expensive. There is a need for setting up clear strategies to stop progression of asthma and COPD by reducing risk factors such as tobacco consumption and environment pollution.
- 1 January 2011
- Published by Muhimbili University of Health and Allied Sciences in East African Journal of Public Health
- Vol. 8 (2) , 173-176
Asthma, atopy and COPD in sub-Saharan countries: the challenges.
Asthma and COPD are the most important chronic airways diseases worldwide. Urbanization and westernization of African countries are important factors for the development of chronic respiratory diseases. Unfortunately for many reasons, only few studies on atopy, asthma and COPD have been carried out in Africa and risk factors are not well known on the continent. Moreover, in many African countries drugs for asthma and COPD are either lacking or expensive. There is a need for setting up clear strategies to stop progression of asthma and COPD by reducing risk factors such as tobacco consumption and environment pollution.